Centene Corp

CNC: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$35.00MwdtgVgggnwt

Centene Earnings: 2023 Outlook Raised as Individual Expansion Offsets Medicaid Redeterminations

Narrow-moat Centene turned in strong third-quarter results even as Medicaid redeterminations continued. With the expansion of its individual exchange business more than offsetting Medicaid declines, management moderately increased its 2023 outlook and maintained its 2024 guidance. At first glance, these goals appear to be in line with our expectations, and we are maintaining our $87 fair value estimate. Centene shares remain moderately undervalued, in our view.

Sponsor Center